Listed

NextCure, Inc.

NXTCNasdaqCIK 1661059HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$15.1m, Q2 FY2026
Net income−$14.9m, Q2 FY2026
NextCure, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m11.0Research and development, Q3 FY2023, three months to 2023-09-30$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure11.8Research and development, Q4 FY2023, three months to 2023-12-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0001558370-25-002402. Derived: 12-month figure less the 9-month figure.Report this figure11.4Research and development, Q1 FY2024, three months to 2024-03-31$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure12.4Research and development, Q2 FY2024, three months to 2024-06-30$12.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure8.8Research and development, Q3 FY2024, three months to 2024-09-30$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure8.9Research and development, Q4 FY2024, three months to 2024-12-31$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure7.9Research and development, Q1 FY2025, three months to 2025-03-31$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure24.1Research and development, Q2 FY2025, three months to 2025-06-30$24.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure6.1Research and development, Q3 FY2025, three months to 2025-09-30$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure6.8Research and development, Q4 FY2025, three months to 2025-12-31$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure6.8Research and development, Q1 FY2026, three months to 2026-03-31$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure7.4Research and development, Q2 FY2026, three months to 2026-06-30$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Operating income$m(15.6)Operating income, Q3 FY2023, three months to 2023-09-30−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure(15.8)Operating income, Q4 FY2023, three months to 2023-12-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0001558370-25-002402. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating income, Q1 FY2024, three months to 2024-03-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure(16.5)Operating income, Q2 FY2024, three months to 2024-06-30−$16.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure(12.5)Operating income, Q3 FY2024, three months to 2024-09-30−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(12.5)Operating income, Q4 FY2024, three months to 2024-12-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(11.6)Operating income, Q1 FY2025, three months to 2025-03-31−$11.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(27.3)Operating income, Q2 FY2025, three months to 2025-06-30−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(8.9)Operating income, Q3 FY2025, three months to 2025-09-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(9.8)Operating income, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(10.1)Operating income, Q1 FY2026, three months to 2026-03-31−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(15.1)Operating income, Q2 FY2026, three months to 2026-06-30−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figurenot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Net income$m(14.3)Net income, Q3 FY2023, three months to 2023-09-30−$14.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure(14.5)Net income, Q4 FY2023, three months to 2023-12-31−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0001558370-25-002402. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Net income, Q1 FY2024, three months to 2024-03-31−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(15.4)Net income, Q2 FY2024, three months to 2024-06-30−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(11.5)Net income, Q3 FY2024, three months to 2024-09-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(11.6)Net income, Q4 FY2024, three months to 2024-12-31−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Net income, Q1 FY2025, three months to 2025-03-31−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(26.8)Net income, Q2 FY2025, three months to 2025-06-30−$26.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(8.6)Net income, Q3 FY2025, three months to 2025-09-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure(9.4)Net income, Q4 FY2025, three months to 2025-12-31−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(9.8)Net income, Q1 FY2026, three months to 2026-03-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(14.9)Net income, Q2 FY2026, three months to 2026-06-30−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Diluted EPS$ per share(0.51)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figurenot reported(0.61)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure(6.61)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$6.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure(4.95)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported(4.70)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$4.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(11.29)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$11.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(3.22)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$3.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported(1.87)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(2.80)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Basic EPS$ per share(0.51)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figurenot reported(0.61)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure(6.61)Basic EPS, Q2 FY2024, three months to 2024-06-30−$6.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure(4.95)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported(4.70)Basic EPS, Q1 FY2025, three months to 2025-03-31−$4.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(11.29)Basic EPS, Q2 FY2025, three months to 2025-06-30−$11.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure(3.22)Basic EPS, Q3 FY2025, three months to 2025-09-30−$3.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figurenot reported(1.87)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(2.80)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure

Balance sheet

Cash and equivalents$15.3m, Q2 FY2026
Shareholders' equity$12.1m, Q2 FY2026
NextCure, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m19.5Cash and equivalents, Q3 FY2023, at 2023-09-30$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure13.1Cash and equivalents, FY2023, at 2023-12-31$13.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0001558370-25-002402.Report this figure18.4Cash and equivalents, Q1 FY2024, at 2024-03-31$18.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure20.8Cash and equivalents, Q2 FY2024, at 2024-06-30$20.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure27.7Cash and equivalents, Q3 FY2024, at 2024-09-30$27.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure27.7Cash and equivalents, FY2024, at 2024-12-31$27.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure21.8Cash and equivalents, Q1 FY2025, at 2025-03-31$21.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure4.9Cash and equivalents, Q2 FY2025, at 2025-06-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure7.3Cash and equivalents, Q3 FY2025, at 2025-09-30$7.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure26.0Cash and equivalents, FY2025, at 2025-12-31$26.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure15.2Cash and equivalents, Q1 FY2026, at 2026-03-31$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure15.3Cash and equivalents, Q2 FY2026, at 2026-06-30$15.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Current assets$m123Current assets, Q3 FY2023, at 2023-09-30$122.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure113Current assets, FY2023, at 2023-12-31$112.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0001558370-25-002402.Report this figure103Current assets, Q1 FY2024, at 2024-03-31$102.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure90.5Current assets, Q2 FY2024, at 2024-06-30$90.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure78.7Current assets, Q3 FY2024, at 2024-09-30$78.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure71.8Current assets, FY2024, at 2024-12-31$71.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure58.9Current assets, Q1 FY2025, at 2025-03-31$58.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure40.0Current assets, Q2 FY2025, at 2025-06-30$40.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure32.6Current assets, Q3 FY2025, at 2025-09-30$32.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure43.7Current assets, FY2025, at 2025-12-31$43.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure31.7Current assets, Q1 FY2026, at 2026-03-31$31.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure22.3Current assets, Q2 FY2026, at 2026-06-30$22.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Total assets$m140Total assets, Q3 FY2023, at 2023-09-30$139.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure128Total assets, FY2023, at 2023-12-31$128.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0001558370-25-002402.Report this figure115Total assets, Q1 FY2024, at 2024-03-31$115.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure103Total assets, Q2 FY2024, at 2024-06-30$102.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure90.3Total assets, Q3 FY2024, at 2024-09-30$90.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure80.9Total assets, FY2024, at 2024-12-31$80.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure67.1Total assets, Q1 FY2025, at 2025-03-31$67.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure47.7Total assets, Q2 FY2025, at 2025-06-30$47.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure39.6Total assets, Q3 FY2025, at 2025-09-30$39.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure50.2Total assets, FY2025, at 2025-12-31$50.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure38.0Total assets, Q1 FY2026, at 2026-03-31$38.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure22.6Total assets, Q2 FY2026, at 2026-06-30$22.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Current liabilities$m6.6Current liabilities, Q3 FY2023, at 2023-09-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure6.9Current liabilities, FY2023, at 2023-12-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0001558370-25-002402.Report this figure9.6Current liabilities, Q1 FY2024, at 2024-03-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure10.8Current liabilities, Q2 FY2024, at 2024-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure8.7Current liabilities, Q3 FY2024, at 2024-09-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure9.6Current liabilities, FY2024, at 2024-12-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure5.7Current liabilities, Q1 FY2025, at 2025-03-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure10.8Current liabilities, Q2 FY2025, at 2025-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure11.0Current liabilities, Q3 FY2025, at 2025-09-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure10.6Current liabilities, FY2025, at 2025-12-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure6.9Current liabilities, Q1 FY2026, at 2026-03-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure6.4Current liabilities, Q2 FY2026, at 2026-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Total liabilities$m13.5Total liabilities, Q3 FY2023, at 2023-09-30$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure13.6Total liabilities, FY2023, at 2023-12-31$13.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0001558370-25-002402.Report this figure16.1Total liabilities, Q1 FY2024, at 2024-03-31$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure17.1Total liabilities, Q2 FY2024, at 2024-06-30$17.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure14.8Total liabilities, Q3 FY2024, at 2024-09-30$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure15.4Total liabilities, FY2024, at 2024-12-31$15.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure11.3Total liabilities, Q1 FY2025, at 2025-03-31$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure16.0Total liabilities, Q2 FY2025, at 2025-06-30$16.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure16.0Total liabilities, Q3 FY2025, at 2025-09-30$16.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure15.2Total liabilities, FY2025, at 2025-12-31$15.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure11.3Total liabilities, Q1 FY2026, at 2026-03-31$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure10.5Total liabilities, Q2 FY2026, at 2026-06-30$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m126Shareholders' equity, Q3 FY2023, at 2023-09-30$126.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure114Shareholders' equity, FY2023, at 2023-12-31$114.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001104659-26-024137.Report this figure99.0Shareholders' equity, Q1 FY2024, at 2024-03-31$99.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure85.4Shareholders' equity, Q2 FY2024, at 2024-06-30$85.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure75.6Shareholders' equity, Q3 FY2024, at 2024-09-30$75.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure65.5Shareholders' equity, FY2024, at 2024-12-31$65.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure55.9Shareholders' equity, Q1 FY2025, at 2025-03-31$55.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure29.6Shareholders' equity, Q2 FY2025, at 2025-06-30$29.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure23.6Shareholders' equity, Q3 FY2025, at 2025-09-30$23.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure34.9Shareholders' equity, FY2025, at 2025-12-31$34.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure26.7Shareholders' equity, Q1 FY2026, at 2026-03-31$26.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure12.1Shareholders' equity, Q2 FY2026, at 2026-06-30$12.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure

Cash flow

Operating cash flow−$9.7m, Q2 FY2026
Capital expenditure−$34.0k, Q4 FY2024
NextCure, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014869. Derived: 9-month figure less the 6-month figure.Report this figure(10.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0001558370-25-002402. Derived: 12-month figure less the 9-month figure.Report this figure(12.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure(9.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001558370-25-010782. Derived: 6-month figure less the 3-month figure.Report this figure(11.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107036. Derived: 9-month figure less the 6-month figure.Report this figure(7.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(13.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(22.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001104659-26-092050. Derived: 6-month figure less the 3-month figure.Report this figure(6.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107036. Derived: 9-month figure less the 6-month figure.Report this figure(7.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figure(13.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure(9.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001104659-26-092050. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$279.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001558370-24-014869. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001558370-25-002402. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$301.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001558370-25-010782. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$170.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001104659-25-107036. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001104659-26-024137. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)5.31m, Q2 FY2026
NextCure, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares27.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3027,748,844 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001558370-23-017429.Report this figure27.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3127,774,536 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001558370-24-006551.Report this figure27.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3027,828,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001558370-24-010605.Report this figure27.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3027,839,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001558370-24-014869.Report this figure27.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,903,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001558370-25-006111.Report this figure2.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-302,331,062 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001558370-25-010782.Report this figure2.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-302,331,320 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure2.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-312,333,890 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure2.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-302,374,729 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure2.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-302,676,116 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001104659-25-107036.Report this figure5.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-315,239,236 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057187.Report this figure5.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-305,309,724 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure

Shares outstanding: 4.58mShares outstanding, period not labelled, at 2026-07-314,577,359 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-092050.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.